Filler G, Amendt P, von Bredow M A, Rohde W, Ehrich J H
Department of Paediatric Nephrology, Charité Children's Hospital, Humboldt University Berlin, Germany.
Eur J Pediatr. 1998 Sep;157(9):738-42. doi: 10.1007/s004310050926.
Infantile cystinosis, a rare lysosomal storage disease of cystine, leads to Fanconi syndrome and end-stage renal failure. After renal transplantation, no recurrence of the disease occurs in the graft, but other organ involvement becomes evident later in life. Diabetes mellitus has been associated with cystinosis, but the mechanisms of impaired glucose tolerance have not yet been characterized. Here, we studied glucose tolerance, glucose constant decay (k-values), insulin and C-peptide by intravenous glucose tolerance test (IVGTT) in eight patients with infantile cystinosis (three with impaired GFR (CRF) and five after kidney transplantation (KTX)). For comparison, 15 age-matched children with CRF and 15 age-matched KTX patients were analysed. Both early and second insulin secretion phases were diminished in patients with infantile cystinosis, whereas in CRF, k-values were no different from control patients. After renal transplantation, k-values were significantly lower in cystinotic patients with a markedly reduced early insulin secretion phase. There was a significant negative correlation between k-values and age in patients with cystinosis. Repetitive IVGTTs in these patients demonstrated progressive but rather slow loss of first phase insulin secretion and C-peptide production, suggesting a slowly reducing secretion potential of the beta cell due to cystine storage.
Unlike type I diabetes mellitus, glucose intolerance in patients with infantile cystinosis is characterized by a slow, progressive loss of insulin secretion and C-peptide production. For these patients, the data indicate a 50% risk of developing glucose intolerance by the age of 18 years. We recommend to perform intravenous glucose tolerance tests at 5-year intervals.
婴儿胱氨酸病是一种罕见的胱氨酸溶酶体贮积病,可导致范科尼综合征和终末期肾衰竭。肾移植后,移植物中不会出现疾病复发,但其他器官受累在生命后期会变得明显。糖尿病与胱氨酸病有关,但糖耐量受损的机制尚未明确。在此,我们通过静脉葡萄糖耐量试验(IVGTT)研究了8例婴儿胱氨酸病患者(3例肾小球滤过率(GFR)受损(慢性肾衰竭(CRF))和5例肾移植(KTX)后患者)的糖耐量、葡萄糖持续衰减(k值)、胰岛素和C肽。为作比较,分析了15例年龄匹配的CRF儿童和15例年龄匹配的KTX患者。婴儿胱氨酸病患者的早期和第二胰岛素分泌阶段均减少,而在CRF患者中,k值与对照患者无差异。肾移植后,早期胰岛素分泌阶段明显降低的胱氨酸病患者的k值显著更低。胱氨酸病患者的k值与年龄之间存在显著负相关。对这些患者进行重复IVGTT显示,第一阶段胰岛素分泌和C肽产生逐渐但相当缓慢地丧失,提示由于胱氨酸贮积,β细胞的分泌潜能逐渐降低。
与1型糖尿病不同,婴儿胱氨酸病患者的糖耐量异常表现为胰岛素分泌和C肽产生缓慢、进行性丧失。对于这些患者,数据表明18岁时发生糖耐量异常的风险为50%。我们建议每5年进行一次静脉葡萄糖耐量试验。